Glenza 40mg tablet: Enzalutamide Price, Uses & Side effects

GLENZA 40MG




Glenza 40mg tablet is a non steroidal anti-androgen drug; by inhibiting the androgen synthesis and expels anti-neoplastic activity against prostate tumor. Glenza 40mg is an oral tablet form, which is endorsed by FDA. Enzalutamide is related with a reducing rate of serum enzyme increased during treatment, be that as it may, have not been connected to instances of clinically clear liver damage with jaundice.


Product Details

Trade name :Glenza 
Active component : Enzalutamide 
Strength :40MG 
Manufactured by :Glenmark Pharmaceuticals Ltd 
Pack :28 capsules

Glenza 40mg
Glenza 40mg tablet

Mechanism of action

Androgen is a male hormone; testosterone is a one of the hormone secreted from androgen which is responsible for growth of the tumor cells present in the prostate glands. Glenza 40 mg tablets are comprises of Enzalutamide which acts by inhibiting the binding of androgen into androgen receptor site. This inhibition leads to interfere with signal transduction of receptors and causes growth retardation. The active metabolite of Enzalutamide is N-desmethyl Enzalutamide which is similar to parent form. Glenza exhibits anti-neoplastic effect by reducing the cell proliferation leads to cell death and reduce the tumor cell volume.


Pregnancy

The pregnancy category of Enzalutamide X, which means it, may cause fetal harm even to death. Glenza 40mg should not be recommended in pregnancy conditions.


Side Effects

Peripheral edema, Back pain, Arthralgia, Musculoskeletal pain, Musculoskeletal stiffness, weakness, Diarrhea, Hot flush, Hypertension, Head ache, Dizziness, Mental impairment, Hypoesthesia, Respiratory tract infection, Insomnia, Anxiety, Hematuria, Pollakiuria, Fall associated injuries, Non pathogenic fractures, Pruritus, Dry skin, Epistaxis, Elevation of AST & ALT, Elevation of bilirubin, Sepsis, Hallucination.



Prescription Medication Policy

Anti-Cancer-Drugs.com, a fully licensed and regulated pharmacy, takes all precautions to strictly abide by the laws and regulations set forth in the dispensing of prescription medications. By placing the order for your prescription medicines, you acknowledge and accept the following terms regarding the purchase of any prescription medicines.

Comments

Post a Comment

Popular posts from this blog

Lapahope 250mg tablet online | Apple pharmaceuticals

LAPAHOPE 250MG Description Lapahope 250mg tablet belongs to class of anti-neoplastic drugs which prevents the development and spreading of cancer cells all over the body. Lapahope is indicated for metastatic breast cancer and spreading after using of other chemotherapy drugs. Product Details Trade name :Lapahope  Active component : Lapatinib   Strength :250 mg  Manufactured by :Natco Pharma  Packing: 150 Tablets Mechanism Of Action Lapahope is a type of classification called kinase inhibitor and act by intracellular tyrosine kinase.  Lapahope prohibits ErbB-forced tumor cell growth in vitro and in various animal models. When combination 5-fluracil with Lapahope created an additive effect in the 4 tumor cell lines tested. Development inhibits the Lapahope tablet effect were examined in trastuzumab-conditioned cell lines.  Lapahope provide selective action against breast cancer cell lines selected for long-term growth in trastuzumab-containing intra
Read more

Xtandi 40mg tablet - Enzalutamide

Image
XTANDI 40MG Xtandi 40mg  is a non steroidal anti-androgen drug; by inhibiting the androgen synthesis and expels anti-neoplastic activity against prostate tumor. Xtandi 40mg is an oral tablet form, which is endorsed by FDA. Enzalutamide is related with a reducing rate of serum enzyme increased during treatment, be that as it may, have not been connected to instances of clinically clear liver damage with jaundice. Xtandi 40mg Tablet Enzalutamide Mechanism of action Androgen is a male hormone; testosterone is a one of the hormone secreted from androgen which is responsible for growth of the tumor cells present in the prostate glands. Xtandi 40 mg tablets are comprises of  Enzalutamide  which acts by inhibiting the binding of androgen into androgen receptor site. This inhibition leads to interfere with signal transduction of receptors and causes growth retardation. The active metabolite of Enzalutamide is N-desmethyl Enzalutamide which is similar to parent form. Xtandi e
Read more